Skip to content
MedsAcross

Medicine

Hydroxyurea 500 mg capsule

Hydroxyurea · Oral
Available on requestPrescription onlyUS FDAGeneric name

Hydroxyurea 500 mg capsule is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF).

Key facts

Active ingredient (INN)
Hydroxyurea
Brand
Sold under the generic name
Strength
500 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 100 blister pack, 30 capsules and 7 more
Manufacturers
American Health PackagingAvKARECouplerGolden State Medical SupplyLeading PharmaMajor PharmaceuticalsPar HealthQilu PharmaceuticalSomerset TherapeuticsTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L01XX05 Hydroxyurea
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 October 1998
Identifiers
RxCUI 197797DailyMed set ID b9514ae5-79ae-4cc2-9d7f-c8f7806d1694, e76fd60e-7644-48c5-9857-3608a045000b, 4c4e1c2f-2143-44f3-8825-aeba42e755e4 +7NDC 0555-0882, 0904-6939, 69315-164 +7Application ANDA075143, ANDA075340, ANDA213438 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle, plastic69315-164-01Leading Pharma9 July 2020
100 capsule in 1 bottle49884-724-01Par Health24 February 1999
100 capsule in 1 bottle67184-0607-1Qilu Pharmaceutical6 March 2024
100 capsule in 1 bottle70069-820-01Somerset Therapeutics18 June 2024
100 capsule in 1 bottle0555-0882-02Teva Pharmaceuticals19 October 1998
100 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack68084-284-01American Health Packaging17 September 2008
100 capsule in 1 bottle42291-321-01AvKARE23 July 2013
30 capsule in 1 blister pack67046-1619-3Coupler2 December 2025
100 capsule in 1 bottle, plastic51407-909-01Golden State Medical Supply22 April 2024
100 blister pack in 1 carton / 1 capsule in 1 blister pack0904-6939-61Major Pharmaceuticals24 February 1999

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 7 December 1967Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Hydroxyurea 500 mg capsule.

Compare 1

Other strengths and forms of Hydroxyurea

Clinical summary

Hydroxyurea is an antimetabolite indicated to reduce the frequency of painful crises and to reduce the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises. MedsAcross supplies Hydroxyurea for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Hydroxyurea

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Hydroxyurea 500 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.